Coronavirus Disease (COVID-19): 10 Questions and Discussion Points for Diabetes and COVID-19

被引：1

作者：

Ebrahimpur, Mahbube ^{[1
]}

Payab, Moloud ^{[2
]}

Sani, Mahnaz Pejman ^{[3
]}

Larijani, Bagher ^{[4
]}

机构：

[1] Univ Tehran Med Sci, Elderly Hlth Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran

[2] Univ Tehran Med Sci, Obes & Eating Habits Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran

[3] Univ Tehran Med Sci, Shariati Hosp, Dept Internal Med, Tehran, Iran

[4] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran

来源：

FRONTIERS IN EMERGENCY MEDICINE | 2021年 / 5卷 / 02期

关键词：

Clinical Management; COVID-19; Diabetes; Pathogenesis; SARS-CoV-2; MELLITUS;

D O I：

10.18502/fem.v5i2.5625

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

The COVID-19 pandemic is now an international concern. COVID-19 is first reported in Wuhan, China on 31 December 2019 and affects different people in different ways. Evidence suggests that people with underlying disease are at higher risk for more severe disease. People with diabetes are not only more likely than the general population to have COVID-19 but also they are among those high-risk categories that can have serious illness if they get the virus.

引用

页数：4

共 14 条

[1] Practical recommendations for the management of diabetes in patients with COVID-19 [J].

Bornstein, Stefan R. ;

Rubino, Francesco ;

Khunti, Kamlesh ;

Mingrone, Geltrude ;

Hopkins, David ;

Birkenfeld, Andreas L. ;

Boehm, Bernhard ;

Amiel, Stephanie ;

Holt, Richard I. G. ;

Skyler, Jay S. ;

DeVries, J. Hans ;

Renard, Eric ;

Eckel, Robert H. ;

Zimmet, Paul ;

George Alberti, Kurt ;

Vidal, Josep ;

Geloneze, Bruno ;

Chan, Juliana C. ;

Ji, Linong ;

Ludwig, Barbara .

LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (06) :546-550

[2] COVID-19 and diabetes management: What should be considered? [J].

Ceriello, Antonio ;

Stoian, Anca Pantea ;

Rizzo, Manfredi .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 163

[3]

Ebrahimpur M, 2018, ADV J EMERG MED, V2, DOI [10.22114/ajem.v0i0.59, 10.22114/AJEM.v0i0.59]

[4] Prevalence and impact of diabetes among people infected with SARS-CoV-2 [J].

Fadini, G. P. ;

Morieri, M. L. ;

Longato, E. ;

Avogaro, A. .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (06) :867-869

[5]

Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1

[6] Clinical considerations for patients with diabetes in times of COVID-19 epidemic [J].

Gupta, Ritesh ;

Ghosh, Amerta ;

Singh, Awadhesh Kumar ;

Misra, Anoop .

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (03) :211-212

[7] Commentary: COVID-19 in patients with diabetes [J].

Hill, Michael A. ;

Mantzoros, Christos ;

Sowers, James R. .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 107

[8] Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia A systematic review, meta analysis, and meta-regression [J].

Huang, Ian ;

Lim, Michael Anthonius ;

Pranata, Raymond .

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) :395-403

[9] COVID-19 and diabetes: Knowledge in progress [J].

Hussain, Akhtar ;

Bhowmik, Bishwajit ;

do Vale Moreira, Nayla Cristina .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162

[10] Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature [J].

Katulanda, Prasad ;

Dissanayake, Harsha A. ;

Ranathunga, Ishara ;

Ratnasamy, Vithiya ;

Wijewickrama, Piyumi S. A. ;

Yogendranathan, Nilukshana ;

Gamage, Kavinga K. K. ;

de Silva, Nipun L. ;

Sumanatilleke, Manilka ;

Somasundaram, Noel P. ;

Matthews, David R. .

DIABETOLOGIA, 2020, 63 (08) :1440-1452

← 1 2 →